Your browser doesn't support javascript.
loading
[18F]FDG PET/CT versus [18F]FDG PET/MRI in the evaluation of liver metastasis in patients with primary cancer: A head-to-head comparative meta-analysis.
Shi, Yige; Yu, Hanxiang; Zhang, Xiaoyang; Xu, Xing; Tuo, Hongfang.
Afiliação
  • Shi Y; Department of Graduate College, Hebei Medical University, Shijiazhuang 050011, China; Department of Hepatobiliary Surgery, Hebei General Hospital, Shijiazhuang 050051, China.
  • Yu H; Department of Hepatobiliary Surgery, Hebei General Hospital, Shijiazhuang 050051, China.
  • Zhang X; Department of Hepatobiliary Surgery, Hebei General Hospital, Shijiazhuang 050051, China; Department of Graduate college, North China University of Science and Technology, Tangshan 063210,China.
  • Xu X; Department of Hepatobiliary Surgery, Hebei General Hospital, Shijiazhuang 050051, China; Department of Graduate college, North China University of Science and Technology, Tangshan 063210,China.
  • Tuo H; Department of Hepatobiliary Surgery, Hebei General Hospital, Shijiazhuang 050051, China. Electronic address: tuohongfang2023@163.com.
Clin Imaging ; 112: 110209, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38833916
ABSTRACT

PURPOSE:

This meta-analysis aimed to compare the diagnostic effectiveness of [18F]FDG PET/CT with that of [18F]FDG PET/MRI in terms of identifying liver metastasis in patients with primary cancer.

METHODS:

PubMed, Embase, Web of Science, and the Cochrane Library were searched, and studies evaluating the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in patients with liver metastasis of primary cancer were included. We used a random effects model to analyze their sensitivity and specificity. Subgroup analyses and corresponding meta-regressions focusing on race, image analysis, study design, and analysis methodologies were conducted. Cochrane Q and I2 statistics were used to assess intra-group and inter-group heterogeneity.

RESULTS:

Seven articles with 343 patients were included in this meta-analysis. The sensitivity of [18F]FDG PET/CT was 0.82 (95 % CI 0.63-0.96), and that of [18F]FDG PET/MRI was 0.91 (95 % CI 0.82-0.98); there was no significant difference between the two methods (P = 0.32). Similarly, both methods showed equal specificity 1.00 (95 % CI 0.95-1.00) for [18F]FDG PET/CT and 1.00 (95 % CI 0.96-1.00) for [18F]FDG PET/MRI, and thus, there was no significant difference between the methods (P = 0.41). Furthermore, the subgroup analyses revealed no differences. Meta-regression analysis revealed that race was a potential source of heterogeneity for [18F]FDG PET/CT (P = 0.01), while image analysis and contrast agent were found to be potential sources of heterogeneity for [18F]FDG PET/MRI (P = 0.02).

CONCLUSIONS:

[18F]FDG PET/MRI has similar sensitivity and specificity to [18F]FDG PET/CT for detecting liver metastasis of primary cancer in both the general population and in subgroups. [18F]FDG PET/CT may be a more cost-effective option. However, the conclusions of this meta-analysis are tentative due to the limited number of studies included, and further research is necessary for validation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Sensibilidade e Especificidade / Compostos Radiofarmacêuticos / Fluordesoxiglucose F18 / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Clin Imaging Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Sensibilidade e Especificidade / Compostos Radiofarmacêuticos / Fluordesoxiglucose F18 / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Clin Imaging Ano de publicação: 2024 Tipo de documento: Article